FDA Inspection 1117577 — AbbVie Clinical Pharmacology Research Unit (ACPRU)
The FDA completed an inspection of AbbVie Clinical Pharmacology Research Unit (ACPRU) on Jan 10, 2020 in Grayslake, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 10, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Grayslake, IL (United States)
Additional Details
Clinical BA/BE